Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_assertion type Assertion NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_head.
- NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_assertion description "[By univariate analysis, OS was negatively influenced by the presence of TP53 mutation (median OS 12.4 months versus 23.7 months, p<10(-4)), abnormal cytogenetics (median OS 14.4 months vs 33 months, p=0.02) complex cytogenetics (median OS 12.7 months versus 23.7 months, p=0.0005), and a diagnosis of AML (median 14.5 months vs 21.2 months for MDS or CMML, p=0.02).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_provenance.
- NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_assertion evidence source_evidence_literature NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_provenance.
- NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_assertion SIO_000772 24836762 NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_provenance.
- NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_assertion wasDerivedFrom befree-2016 NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_provenance.
- NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_assertion wasGeneratedBy ECO_0000203 NP1183163.RA45s3INlZY4DeJengXC5hXodcfk0zrGnhPkhd3GG2I_M130_provenance.